Frank Yocca

BTAI

Frank Yocca serves as officer: Chief Scientific Officer at BioXcel Therapeutics, Inc. (BTAI). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

9 trades

$2.26M

Net Position

Net Seller

$2.26M

Companies Traded

BTAI

Active Period

Mar 2021 – May 2026

9 total trades

Most Recent

Sell BTAI

May 22, 2026 · $7.4K

Frank Yocca's Insider Trading at BioXcel Therapeutics, Inc. (BTAI)

Buys

0 · $0.00

Sells

9 · $2.26M

Total Shares Bought

Total Shares Sold

82,024

BTAI Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 22, 2026	Sell	6,845	$1.08	$7.4K	26,175
Dec 14, 2024	Sell	225	$0.35	$79.02	0
Sep 17, 2024	Sell	7,175	$0.55	$3.9K	0
Sep 14, 2024	Sell	355	$0.69	$244.70	0
Jun 14, 2024	Sell	372	$1.28	$476.16	0
Mar 14, 2024	Sell	1,067	$2.63	$2.8K	0
Mar 14, 2023	Sell	985	$19.69	$19.4K	0
Jan 20, 2023	Sell	50,000	$30.00	$1.50M	0
Mar 15, 2021	Sell	15,000	$48.50	$727.6K	0

Related Insiders

Vimal Mehta

director, officer: CEO and President

BTAISell · May 22, 2026

Javier Rodriguez

officer: See Remarks

BTAISell · May 22, 2026

Richard I Steinhart

officer: Chief Financial Officer

BTAISell · May 22, 2026

Explore More Insider Trading Data

BTAI Insider Trading Activity

View all insider trades at BioXcel Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity